The DISRUPT-AF Registry is an observational, prospective, multi-center, non-randomized, real-world registry designed to obtain clinical experience with the FARAPULSE Pulsed Field Ablation (PFA) System for the treatment of atrial fibrillation (AF). The data collected for this study will be from a subset of patients enrolled in the pre-existing DISRUPT AF Registry. Additionally, patients in the Full Monitoring Arm may be approached and consented for participation in BOUNCE-AF. The post-ablation monitoring timepoints will reflect the site's standard of care (SOC), which is typically at 6- and 12-months post-ablation. Consented patients will complete 1 survey about their experience after wearing the BodyGuardian at 6-months. Clinical staff that consent will also complete a survey on their experience using BodyGuardian. The clinical staff include those that either directly prescribe the monitor, place the monitor on the patient and/or train the patient on the use of the monitor, or those involved in reviewing the data.
Study Type
OBSERVATIONAL
Enrollment
100
BodyGuardian wear at 6 months
Arrhythmia Center of South Florida
Delray Beach, Florida, United States
RECRUITINGHCA Research Institute (FL Mercy Miami)
Miami, Florida, United States
NOT_YET_RECRUITINGUniversity of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
NOT_YET_RECRUITINGAllegheny General Hospital
Pittsburgh, Pennsylvania, United States
NOT_YET_RECRUITINGSt. Mark's Hospital
Salt Lake City, Utah, United States
NOT_YET_RECRUITINGPrimary Objectives
Results will include arrhythmia recurrence and burden, and subjective data on the patient and clinician experience with BodyGuardian. The study will also evaluate reimbursement patterns for post-ablation monitoring, as well as subject compliance to the physician prescribed monitoring duration.
Time frame: From enrollment to the end of BodyGuardian wear at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.